Updated Jul 16, 2026
Vivaldi Coelho Rogerio has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $301K.
Vivaldi Coelho Rogerio is associated with Viatris Inc, a global healthcare company formed in 2020 through the merger of Mylan and Upjohn, a division of Pfizer. Specific details about his role and contributions to the company are not widely documented.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale | 3.0K | $40.00 | $120K |
| 2026-06-22 | CRNX | Crinetics Pharmaceuticals, Inc. | A — Grant or award | 5.9K | $0.00 | |
| 2026-03-13 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 523 | $36.77 | $19K |
| 2026-03-13 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 4.5K | $36.08 | $162K |
| 2026-03-10 | VTRS | Viatris Inc | M — Option exercise | 1.2K | $0.00 | |
| 2026-03-10 | VTRS | Viatris Inc | M — Option exercise | 23.7K | $0.00 |
Vivaldi Coelho Rogerio is associated with Viatris Inc, a global healthcare company formed in 2020 through the merger of Mylan and Upjohn, a division of Pfizer. Specific details about his role and contributions to the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($301K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Vivaldi Coelho Rogerio profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.